Bortezomib, Dexamethasone and Rituximab in Newly Diagnosed Patients with WaldenstroM's Macroglobulinemia: Final Analysis of a Phase 2 Study after a Minimum Follow up of 6 Years
Autor: | Gavriatopoulou, Maria Garcia-Sanz, Ramon Kastritis, Efstathios and Morel, Pierre Kyrtsonis, Marie-Christine Michalis, Evridiki and Kartasis, Zafeirios Leleu, Xavier Palladini, Giovanni and Tedeschi, Alessandra Gika, Dimitra Merlini, Giampaolo and Sonneveld, Pieter Dimopoulos, Meletios A. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Databáze: | OpenAIRE |
Externí odkaz: |